References of "CAVALIER, Etienne"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailDosage de la vitamine D : attention aux erreurs analytiques!
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 368

Detailed reference viewed: 34 (4 ULg)
Full Text
Peer Reviewed
See detailUn nouveau marqueur tumoral pour le carcinome parathyroïdien? Résultats observés chez 24 patients
Cavalier, Etienne ULg; Daly, Adrian ULg; Betea, Daniela ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 350-351

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailVitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.
Souberbielle, J. C.; Body, J. J.; Lappe, J. M. et al

in Autoimmunity Reviews (2010), 9(11), 709-15

BACKGROUND: There is increasing evidence that, in addition to the well-known effects on musculoskeletal health, vitamin D status may be related to a number of non-skeletal diseases. An international ... [more ▼]

BACKGROUND: There is increasing evidence that, in addition to the well-known effects on musculoskeletal health, vitamin D status may be related to a number of non-skeletal diseases. An international expert panel formulated recommendations on vitamin D for clinical practice, taking into consideration the best evidence available based on published literature today. In addition, where data were limited to smaller clinical trials or epidemiologic studies, the panel made expert-opinion based recommendations. METHODS: Twenty-five experts from various disciplines (classical clinical applications, cardiology, autoimmunity, and cancer) established draft recommendations during a 2-day meeting. Thereafter, representatives of all disciplines refined the recommendations and related texts, subsequently reviewed by all panelists. For all recommendations, panelists expressed the extent of agreement using a 5-point scale. RESULTS AND CONCLUSION: Recommendations were restricted to clinical practice and concern adult patients with or at risk for fractures, falls, cardiovascular or autoimmune diseases, and cancer. The panel reached substantial agreement about the need for vitamin D supplementation in specific groups of patients in these clinical areas and the need for assessing their 25-hydroxyvitamin D (25(OH)D) serum levels for optimal clinical care. A target range of at least 30 to 40 ng/mL was recommended. As response to treatment varies by environmental factors and starting levels of 25(OH)D, testing may be warranted after at least 3 months of supplementation. An assay measuring both 25(OH)D(2) and 25(OH)D(3) is recommended. Dark-skinned or veiled individuals not exposed much to the sun, elderly and institutionalized individuals may be supplemented (800 IU/day) without baseline testing. [less ▲]

Detailed reference viewed: 48 (4 ULg)
Full Text
Peer Reviewed
See detailAnalytical validation of the Liaison hGH assay (DiaSorin)
Keutgens, Aurore ULg; Ho, Thi Thanh Giang ULg; Cavalier, Etienne ULg

in European NeuroEndocrine Association (2010, September)

Detailed reference viewed: 41 (4 ULg)
Full Text
See detailVitamin D and cardiovascular diseases: Where do we stand in 2010?
Cavalier, Etienne ULg

in Lipid Club Letter (2010), 22(3), 2-3

Detailed reference viewed: 32 (0 ULg)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 221 (5 ULg)
Full Text
Peer Reviewed
See detailDétection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 33 (3 ULg)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 367-68

Detailed reference viewed: 15 (0 ULg)
See detailHigh Kisspeptine-10 levels in obese hypogonadic patients : is kisspeptine-10 a periheral signal between metabolism and reproduction
Valdes Socin, Hernan Gonzalo ULg; Cavalier, Etienne ULg; Beckaert, A. C. et al

in European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September)

Detailed reference viewed: 36 (8 ULg)
Full Text
Peer Reviewed
See detailThe Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma.
Cavalier, Etienne ULg; Daly, Adrian ULg; Betea, Daniela ULg et al

in Journal of Clinical Endocrinology and Metabolism (2010), 95

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is ... [more ▼]

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is recognized by third-generation but not by second-generation PTH immunoassays. In normal individuals, the third-generation to second-generation PTH ratio should be less than 1. Objective: Our objective was to study the utility of the third-generation to second-generation PTH ratio as a means of distinguishing PCa patients (n = 24) from control groups with and without disorders of calcium secretion, including patients on renal hemodialysis (n = 74), postrenal transplantation (n = 60), and primary hyperparathyroidism (PHP; n = 30). Setting and Design: We conducted a retrospective, laboratory-based study at tertiary referral academic centers. Results: The mean third-generation to second-generation ratio was 0.58 ± 0.10 in the dialysis patients, 0.54 ± 0.10 in the renal transplant group, 0.54 ± 0.12 in the elderly healthy patients, and 0.68 ± 0.11 in the PHP group. All 245 of these patients presented a PTH third-generation to second-generation ratio of less than 1. In contrast, we observed an inverted third-generation to second-generation PTH ratio of more than one in 20 PCa patients, whereas only four PCa patients had a normal ratio of less than 1. Conclusions: An inverted third-generation to second-generation PTH ratio occurred in the majority of patients with advanced PCa and was absent in all 245 relevant controls. A third-generation to second-generation PTH ratio higher than 1 had a sensitivity of 83.3% and a specificity of 100% among PHP patients as a marker for PCa. This ratio may be useful to identify patients with PCa earlier and to detect patients either at risk of developing PCa or those in whom recurrence is taking place. [less ▲]

Detailed reference viewed: 57 (9 ULg)
See detailVitamin D symposium
CAVALIER, Etienne ULg

Conference (2010, June 04)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailValidation of the ImmunoCAP ISAC
Gadisseur, Romy ULg; Blanco Catafal, Anna; Chapelle, Jean-Paul ULg et al

in Clinical Chemistry (2010, June), 56(S6), 97

Detailed reference viewed: 84 (5 ULg)
Full Text
Peer Reviewed
See detailEvaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 188

Detailed reference viewed: 40 (2 ULg)
Full Text
Peer Reviewed
See detailAnalytical validation of the Abbott Architect urine NGAL
Cavalier, Etienne ULg; Saarbach, D.; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 96

Detailed reference viewed: 78 (2 ULg)